Granules India Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:	532482	NSE Symbol:	GRANULES	P/E :	37.39
ISIN Demat:	INE101D01020	Div & Yield %:	0.25	EPS :	15.8
Book Value:	146.23	Market Cap (Rs. Cr.):	14,336.87	Face Value :	1

Date	Headline
05-Mar-26	Granules India's packaging facility in Virginia receives EIR with NAI status
08-Jan-26	Granules receives USFDA approval for generic Amphetamine Extended-Release Tablets
24-Dec-25	Granules India EGM scheduled
22-Dec-25	Granules India arm receives USFDA tentative approval for Amphetamine XR-ODT
18-Dec-25	Granules India schedules board meeting
04-Dec-25	Granules Consumer Health completes USFDA inspection
01-Dec-25	Granules inaugurates two new Centres of Excellence at IIT Hyderabad
11-Nov-25	Granules Life Sciences receives USFDA approval for its Hyderabad unit
05-Nov-25	Granules Pharmaceuticals Inc. concludes USFDA inspection
30-Oct-25	Granules India to conduct board meeting

Company Snapshot